H-1B sponsorship profile: Institute for Cancer Research. Across U.S. Department of Labor LCA disclosures, Institute for Cancer Research filed 54 Labor Condition Applications covering 54 H-1B worker positions between fiscal year 2023 and fiscal year 2025. The employer’s DOL certification rate sits at 100% (54 certified of 54 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Institute for Cancer Research’s H-1B petitions range from $45,240 at the low end to $135,000 at the high end, with a petition-weighted average of $72,620. That range reflects the mix of occupations the company sponsors, led by Postdoctoral Associate (20 petitions at $65,727 avg), followed by Scientific Associate and Service Line Manager . H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Institute for Cancer Research is headquartered in Philadelphia, PA under NAICS code 5417, and places H-1B workers across 1 state, most heavily in PA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Institute for Cancer Research ranks. By H-1B petition volume, Institute for Cancer Research is #4,371 of 119,880 employers nationally and #139 of 3,282 employers headquartered in PA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.